PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer.

James W FrisbieAlexa J Van BesienAdrianna LeeLinhan XuShu WangAnkur ChoksiM Adil AfzalMichael J NaslundBarton F LaneJade WongAmelia WnorowskiMohummad Minhaj Siddiqui

Published in: Prostate cancer and prostatic diseases (2022)

PSAD with a cutoff of 0.1 ng/ml/cc appears to be a useful marker that can stratify the risk of CSPC in a complementary manner to prostate MP-MRI.

Keyphrases

prostate cancer
radical prostatectomy
contrast enhanced
magnetic resonance imaging
diffusion weighted imaging
computed tomography
magnetic resonance